- Home
- IPSC vs BEDU Comparison
IPSC vs BEDU Comparison
Compare IPSC & BEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- BEDU
- Stock Information
- Founded
- IPSC 2019
- BEDU 1994
- Country
- IPSC United States
- BEDU United Kingdom
- Employees
- IPSC N/A
- BEDU N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- BEDU Other Consumer Services
- Sector
- IPSC Health Care
- BEDU Real Estate
- Exchange
- IPSC Nasdaq
- BEDU Nasdaq
- Market Cap
- IPSC 47.4M
- BEDU 54.0M
- IPO Year
- IPSC 2021
- BEDU 2017
- Fundamental
- Price
- IPSC $0.50
- BEDU $1.70
- Analyst Decision
- IPSC Strong Buy
- BEDU
- Analyst Count
- IPSC 5
- BEDU 0
- Target Price
- IPSC $3.33
- BEDU N/A
- AVG Volume (30 Days)
- IPSC 940.0K
- BEDU 1.4K
- Earning Date
- IPSC 08-22-2025
- BEDU 08-15-2025
- Dividend Yield
- IPSC N/A
- BEDU N/A
- EPS Growth
- IPSC N/A
- BEDU N/A
- EPS
- IPSC N/A
- BEDU N/A
- Revenue
- IPSC $114,898,000.00
- BEDU $224,321,752.00
- Revenue This Year
- IPSC $1,590.09
- BEDU N/A
- Revenue Next Year
- IPSC N/A
- BEDU N/A
- P/E Ratio
- IPSC N/A
- BEDU N/A
- Revenue Growth
- IPSC 8286.72
- BEDU N/A
- 52 Week Low
- IPSC $0.34
- BEDU $1.35
- 52 Week High
- IPSC $2.05
- BEDU $2.19
- Technical
- Relative Strength Index (RSI)
- IPSC 41.82
- BEDU 41.46
- Support Level
- IPSC $0.52
- BEDU $1.76
- Resistance Level
- IPSC $0.57
- BEDU $1.91
- Average True Range (ATR)
- IPSC 0.05
- BEDU 0.03
- MACD
- IPSC -0.01
- BEDU -0.01
- Stochastic Oscillator
- IPSC 7.37
- BEDU 0.00
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.